Johns Hopkins' psilocybin smoking-cessation research

Johns Hopkins' psilocybin smoking-cessation research is a named subject in the book’s index, which directs readers to page 78 and pages 360–64. The available passages establish its place in the book’s treatment of psychedelic research, but do not give enough study-specific information to describe its design, participants, treatment procedures, outcomes, or durability of any effect. Its significance here is therefore chiefly as a traceable research topic, not as a clinical result that can be independently characterized from these passages.

Identification and Record

The index lists smoking cessation with references to page 78 and pages 360–64. Those page references mark the subject’s appearances in the book; the index entry itself does not say what was tested, how many people took part, or what happened to them. It also provides no outcome measure or follow-up period. Accordingly, the available record does not support claims about the study’s success rate, comparative effectiveness, or the role of any particular feature of the psilocybin experience.

Johns Hopkins in the Research Landscape

Elsewhere, the book describes Johns Hopkins researchers as working within a renewed university-based field that had connections to practitioners outside formal research institutions. The account notes that underground guides were sometimes recruited to help train a new cohort of guides for university trials. It also says that when the Hopkins team wanted to study music in guided psilocybin sessions, it asked several underground guides about their musical practices. This establishes a broader institutional interest in how guided sessions were conducted; it does not establish that music or those consultations formed part of the smoking-cessation research.

The surrounding discussion presents the relationship between university research and underground practice as cautious but permeable. Some practitioners carried experience and working knowledge across that boundary, while academic researchers could be reluctant to acknowledge the extent of the exchange. That context helps locate the Hopkins smoking-cessation topic within a field shaped by both formal studies and accumulated therapeutic practice, without supplying details about the smoking study itself.

Evidentiary Limits

The text available for this entry does not connect a particular participant, protocol, or finding to the indexed smoking-cessation references. Nor does it show whether the study was a pilot, how smoking behavior was measured, whether there was a comparison group, or how long participants were followed. Those omissions matter: the existence of an indexed research topic is not, by itself, evidence of efficacy. The grounded account is therefore narrow—the book records Johns Hopkins' psilocybin smoking-cessation research as a subject and places Hopkins within a wider guided-research landscape, while leaving the study’s specific course and conclusions unstated.